Recursion Pharmaceuticals
About Recursion Pharmaceuticals
Recursion is an AI-driven drug discovery and development company focused on uncovering novel medicines. The company utilizes a platform that integrates disease-specific cellular engineering, unbiased high-dimensional biology, and supercompute-powered foundation models. This approach aims to accelerate the identification and development of potential new medicines, particularly in areas with high unmet medical need such as oncology and rare diseases.
The company’s end-to-end learning system, described as a “lab-in-the-loop,” combines physical automation and machine learning models. This system connects biology, precision design, and translational clinical tools to systematically de-risk drug discovery. Recursion’s pipeline includes investigational medicines in various stages of development, from preclinical to Phase 1/2 clinical trials, targeting conditions like familial adenomatous polyposis, solid tumors, and hematologic malignancies.
Focus Areas
Business Intelligence
| Technology | Recursion Operating System (OS), a full-stack, AI-native platform integrating automated wet labs, high-throughput cellular imaging (Cell Painting assay), deep learning, and a supercomputer (BioHive-2) to generate and analyze proprietary biological and chemical datasets (>60 petabytes). |
What Physicians Need to Know
Recursion's AI-driven platform aims to accelerate the discovery and development of novel medicines, potentially leading to new therapeutic options for patients in areas of high unmet need, including various cancers, rare diseases, and neurological conditions. Their focus on precision design and an integrated discovery process may result in more targeted and effective treatments. Physicians can anticipate a pipeline of differentiated investigational medicines that have undergone a rigorous, AI-enabled de-risking process.
Videos
News, demos, and interviews about Recursion Pharmaceuticals.
Videos load interactively. If none appear, search YouTube for Recursion Pharmaceuticals →
Frequently Asked Questions
Investors
Who's funded Recursion Pharmaceuticals.
Related Companies
ClinicalTrials.gov is a publicly accessible website and online database of clinical research studies, managed by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). It serves as a central resource for patients, their families, healthcare professionals, and researchers to access comprehensive information on publicly and privately supported clinical studies across a […]
InsightRX provides AI-powered precision medicine software designed to optimize drug therapy from clinical development to the point of care. For physicians and clinical teams, InsightRX offers solutions like InsightRX Nova for Bayesian model-informed dosing, which individualizes drug regimens using validated pharmacokinetic models and real-time patient data. This helps clinicians achieve therapeutic targets more rapidly and […]
Indica Labs is a global leader in AI-powered digital pathology software and services, providing comprehensive solutions for quantitative evaluation and management of whole slide images. Their flagship platforms, HALO® and HALO AI, leverage artificial intelligence and computer vision algorithms to enable fast and precise analysis of tissue samples, which is critical for advancing research and […]
Triomics is an oncology AI company dedicated to transforming how cancer centers manage complex clinical information. The company’s platform utilizes AI agents to meticulously read and interpret comprehensive longitudinal patient records, converting unstructured clinical data—such as notes, pathology reports, imaging results, and genomic panels—into structured, verifiable outputs. This process significantly reduces the manual burden on […]
ClinTrialMatch is an AI-powered digital health platform designed to optimize patient recruitment, enrollment, and retention in clinical trials. The platform aims to bridge the gap between patients seeking treatment options and clinical trials needing participants by leveraging AI-driven insights. It is currently an early-stage platform undergoing development and pilot collaboration. For physicians, ClinTrialMatch offers a […]
Evaxion Biotech is a pioneering clinical-stage TechBio company that leverages its proprietary, clinically validated, and scalable AI platform, AI-Immunology™, to decode the human immune system. This platform is used to discover and develop novel immunotherapies for cancer, infectious diseases, and increasingly, autoimmune diseases. The company’s mission is to transform patients’ lives by providing inventive and […]
